Labshake search
Citations for Tocris :
1 - 50 of 240 citations for Rat Insulin like growth factor binding protein 6 IGFBP6 ELISA Kit since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cell Biology 2021Quote: ... The growth medium was supplemented with 100 ng/mL human recombinant epidermal growth factor (EGF) (R&D) as the major growth-supporting peptide and was further supplemented with 10 µM Y27632 (Tocris), 500 nM A83-01 (Tocris) ...
-
bioRxiv - Developmental Biology 2021Quote: ... fibroblast growth factor 10 (FGF10, 100 ng/ml, Preprotech) and PGE2 (1 mM, Tocris). After 3 passages we treated organoids with X5050 (Calbiochem ...
-
bioRxiv - Biochemistry 2023Quote: ... SKF81297 hydrobromide (D1-like receptor agonist, TOCRIS), quinpirole hydrochloride (D2-like receptor agonist ...
-
bioRxiv - Biochemistry 2023Quote: ... SCH 39166 (D1-like receptor antagonist, TOCRIS), raclopride (D2-like receptor antagonist ...
-
bioRxiv - Biochemistry 2023Quote: ... quinpirole hydrochloride (D2-like receptor agonist, TOCRIS), SCH 39166 (D1-like receptor antagonist ...
-
bioRxiv - Cell Biology 2021Quote: ... Calcium-like peptide 2 (CALP2) and N-(6-aminohexyl)-5-chloro-1-naphthalenesulfonamide hydrochloride (W-7) were obtained from Tocris (Minneapolis, MN). CaM kinase II and calcineurin inhibitors ...
-
bioRxiv - Biochemistry 2022Quote: ... hiPSCs were patterned for 21 days with a growth factor cocktail to promote differentiation toward ventral midbrain neuronal progenitor cells for 11 days (10 mM SB431542, Tocris; 100 nM LDN193189 ...
-
bioRxiv - Neuroscience 2019Quote: ... quinpirole for D2-like receptors (10–50 µM; Tocris); and the D1/D2 receptor co-agonist SKF 83959 (10–50 µM ...
-
bioRxiv - Developmental Biology 2021Quote: ... 7 μg/ml human recombinant Insulin (Tocris), 100 ng/ml recombinant human/mouse FGF8b (Tocris ...
-
bioRxiv - Molecular Biology 2023Quote: ... Male Sprague Dawley (SD) rats (6-10 weeks old) were administered with a single dose of Sugen 5416 (SU) (20mg/kg, Tocris) delivered in CMC vehicle (as previously described)16 or DMSO and placed in hypoxia chambers (10% O2 ...
-
bioRxiv - Neuroscience 2019Quote: ... For dopamine receptor antagonists we used the D1-like antagonist SCH-23390 (10 µM; Tocris); the D2-like antagonists sulpiride (20 µM ...
-
bioRxiv - Bioengineering 2022Quote: ... media with compaction factors (CHIR (1□uM, TOCRIS), IGF2 (25□ng/ml ...
-
bioRxiv - Neuroscience 2021Quote: ... as well as 5 µg/mL insulin (Tocris Bioscience Inc), 1 mM GlutaMAX ...
-
bioRxiv - Neuroscience 2023Quote: ... with stem cells cultured in serum-free floating embryoid body-like aggregates with 1mM of dorsomorphin (Tocris, 3093), 2 mM of A83-01 (Tocris ...
-
bioRxiv - Neuroscience 2019Quote: ... The receptor-selective agonists we used included SKF 81297 for D1-like receptors (10–50 µM; Tocris, Minneapolis, MN); quinpirole for D2-like receptors (10–50 µM ...
-
bioRxiv - Cell Biology 2023Quote: ... and then stimulated with the appropriate agonist (insulin or CL316,243 (Tocris)) in KRP buffer for 30 min at 37°C ...
-
bioRxiv - Neuroscience 2022Quote: ... CaM binding buffer was supplemented with 100μM W-7 (Tocris).
-
bioRxiv - Neuroscience 2021Quote: ... Drug-evoked locomotor-like activities were induced by bath-applying 10 to 14 µM of N-methyl- D-aspartate (NMDA, Tocris) and serotonin (5-HT ...
-
bioRxiv - Neuroscience 2024Quote: 6-hydroxydopamine (Tocris) injections were performed in WT mice at 8-9 weeks of age ...
-
bioRxiv - Genetics 2019Quote: ... 0.055mM 2-mercaptoethanol and 1ug/ml Insulin) plus 1.5uM Dorsomorphin (Tocris Bioscience) and 10uM SB431542 (Stemgent) ...
-
Striated muscle-specific base editing enables correction of mutations causing dilated cardiomyopathybioRxiv - Genetics 2022Quote: ... medium was changed to RPMI-Insulin with 2 μM Wnt-C59 (Tocris). At day 5 and 7 ...
-
bioRxiv - Neuroscience 2020Quote: ... 0.9% w/v) and 6-OHDA HCl powder (6-hydroxydopamine hydrochloride from Sigma or 6-OHDA hydrobromide from Tocris) was then dissolved to produce a final 6-OHDA concentration of 4.44 mg/ml ...
-
bioRxiv - Cancer Biology 2019Quote: ... For growth inhibition assays with AX15836 (Tocris, Minneapolis, MN) in 2D culture systems ...
-
bioRxiv - Genomics 2023Quote: ... The medium was then exchanged for RPMI-B27-Insulin with Xav (1nM, Tocris) for another 2 days followed by RPMI-B27-Insulin without supplementary cytokines for 3 more days ...
-
bioRxiv - Genetics 2020Quote: ... in the presence of patterning factors SB431542 (Tocris, 1614, 10 µM), XAV939 (Stemgent ...
-
bioRxiv - Developmental Biology 2021Quote: ... CHIR99021 (6 μM; Tocris), FGF2 (20 ng/mL ...
-
bioRxiv - Pharmacology and Toxicology 2020Quote: ... VER (inhibitor of ATP-binding site of Hsp70, Hsc70 and Grp78, Tocris Bioscience ...
-
bioRxiv - Neuroscience 2021Quote: ... [Pro3]-GIP (Rat) was purchased from Tocris, a Bio-Techne brand (Abingdon ...
-
bioRxiv - Biochemistry 2022Quote: ... 0.055 mM 2-mercaptoethanol and 1μg/ml Insulin) plus 1.5 μM Dorsomorphin (Tocris Bioscience) and 10 μM SB431542 (Stemgent ...
-
bioRxiv - Neuroscience 2022Quote: ... and PACAP(6-38) (Tocris). For high K+ stimulation ...
-
bioRxiv - Neuroscience 2022Quote: ... and 6-OHDA (2547, Tocris) were injected into the left hemisphere of substantia nigra pars compacta (SNpc ...
-
bioRxiv - Neuroscience 2023Quote: ... 6-OHDA hydrobromide (Tocris Bioscience) was dissolved in ice-cold 0.02% ascorbic acid dissolved in saline to a concentration of 4 μg/μl ...
-
Critical contribution of mitochondria in the development of cardiomyopathy linked to desmin mutationbioRxiv - Pathology 2023Quote: ... cells were treated with RPMI enriched with insulin-free B27 and 5 µM IWP2 (Tocris Bioscience) for 48 hours and then the medium was replaced with RPMI enriched with insulin-free B27 ...
-
bioRxiv - Neuroscience 2020Quote: ... 250 nM PACAP 6-38 (Tocris), 20 µM Bicuculline (Cayman chemical) ...
-
bioRxiv - Neuroscience 2019Quote: ... 6-OHDA (Tocris; conjugated with HBr) was injected bilaterally in a 4 × 3 grid at AP coordinates 5.1 ...
-
bioRxiv - Neuroscience 2019Quote: ... Rats received injections of NMDA (12.5 µg/µL; Tocris) in saline vehicle at a rate of 0.1 µL/min at the following locations relative to bregma ...
-
bioRxiv - Neuroscience 2021Quote: ... rats were infused with 0.5 μL of muscimol (Tocris) or physiological saline with a flow rate of 0.25 μL/min ...
-
bioRxiv - Biophysics 2024Quote: ... Non- specific ryanodine binding was estimated in the presence of 25 μM unlabeled ryanodine (Tocris) and subtracted from the total binding ...
-
bioRxiv - Developmental Biology 2021Quote: ... the medium was changed to 1mL RPMI+B27 without insulin and supplemented with 12 µM CHIR99021 (Tocris), and changed to 2mL RPMI+B27 without insulin after 24h ...
-
bioRxiv - Genomics 2021Quote: ... we changed the medium to RPMI/B27-insulin supplemented with 1uM Xav 939 (Tocris Bioscience, cat. 3748), and incubated cells for another 48 hours ...
-
bioRxiv - Neuroscience 2020Quote: ... the N3 media was further supplemented with two factors: SB-431542 (5 µM, Tocris, 1614) and LDN-193189 (100 nM ...
-
bioRxiv - Cancer Biology 2020Quote: ... 6-Bnz-cAMP was purchased from Tocris Bioscience (5255) ...
-
bioRxiv - Neuroscience 2020Quote: ... 6-OHDA(100 mg/kg, Tocris, UK) was given every 2 d ...
-
bioRxiv - Cell Biology 2022Quote: ... 3 µM or 6 µM proTAME (Tocris) and mounted in modified rose chambers ...
-
bioRxiv - Cell Biology 2022Quote: ... 3 µM or 6 µM proTAME (Tocris). For monastrol arrest and release experiments ...
-
bioRxiv - Cell Biology 2022Quote: ... 3 µM or 6 µM proTAME (Tocris).
-
bioRxiv - Cell Biology 2022Quote: ... 6 µM or 20 µM proTAME (Tocris) or 2 µM UMK57 or UMK95 during imaging ...
-
bioRxiv - Cell Biology 2023Quote: ... RAC1 inhibitor (CAS1177865-17-6; Tocris Biosciences) was used at 100 µM ...
-
bioRxiv - Cell Biology 2023Quote: ... Rats were treated daily with 1 nmol MC903 (Tocris Bioscience) on ears in the presence of 50 ug OVA (Sigma-Aldrich ...
-
bioRxiv - Physiology 2024Quote: ... injected with 2 mg/kg acylated rat ghrelin (1465, Tocris) solubilized in PBS using an injection volume of 2 mL/kg body weight ...